1-ethyl-2-benzimidazolinone has been researched along with margatoxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahring, PK; Christophersen, P; Hansen, C; Jensen, BS; Jorgensen, TD; Olesen, SP; Silahtaroglu, A; Strobaek, D | 1 |
| Chen, BS; Lo, YC; Wu, SN | 1 |
2 other study(ies) available for 1-ethyl-2-benzimidazolinone and margatoxin
| Article | Year |
|---|---|
Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel.
Topics: Azepines; Benzimidazoles; Calcium; Cell Line; Charybdotoxin; Chromosome Mapping; Chromosomes, Human, Pair 19; Cloning, Molecular; Clotrimazole; Cnidarian Venoms; Humans; In Situ Hybridization, Fluorescence; Intermediate-Conductance Calcium-Activated Potassium Channels; Ketoconazole; Kidney; Membrane Potentials; Miconazole; Neurotoxins; Nitrendipine; Organ Specificity; Potassium Channels; Potassium Channels, Calcium-Activated; Recombinant Proteins; Scorpion Venoms; Transfection | 1998 |
Evidence for aconitine-induced inhibition of delayed rectifier K(+) current in Jurkat T-lymphocytes.
Topics: Aconitine; Animals; Benzimidazoles; Calcium Channel Agonists; Cell Line; Delayed Rectifier Potassium Channels; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Jurkat Cells; Kinetics; Macrophages; Mice; Patch-Clamp Techniques; Scorpion Venoms | 2011 |